AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30134331 — intervention group
Group type: COMPARATOR
Intervention: Placebo and lactulose
Number of subjects: 33
Study 24418368 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU kg(‐1) twice‐weekly prophylaxis regimen
Number of subjects: 50
Study 24418368 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU kg(‐1) once‐weekly prophylaxis regimen
Number of subjects: 50
Study 24418368 — intervention group
Group type: COMPARATOR
Intervention: On-demand therapy
Number of subjects: 50
Study 21757275 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable fixation plates
Number of subjects: 200
Study 21757275 — intervention group
Group type: COMPARATOR
Intervention: Titanium metal plates
Number of subjects: 200
Study 20108160 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Magnesium (Ca/Mg)
Number of subjects: 33
Study 20108160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 19000393 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI within 12 weeks of GP referral including a provisional orthopaedic appointment
Number of subjects: 553
Study 19000393 — intervention group
Group type: COMPARATOR
Intervention: Orthopaedic appointment without prior MRI
Number of subjects: 553
Study 15706463 — intervention group
Group type: EXPERIMENTAL
Intervention: SR142801
Number of subjects: 52
Study 15706463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 12845235 — intervention group
Group type: EXPERIMENTAL
Intervention: PMX-F treatment (group A, n = 10)
Number of subjects: 20
Study 12845235 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (group B, n = 10)
Number of subjects: 20
Study 10827659 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical regular insulin (Iletin‐II) applied four times a day until healed
Number of subjects: 11
Study 10827659 — intervention group
Group type: COMPARATOR
Intervention: Normal saline applied four times a day until healed
Number of subjects: 11
Study 10827659 — intervention group
Group type: COMPARATOR
Intervention: Solution containing the same amount of zinc
Number of subjects: 11
Study 8690827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100‐300 mg/day)
Number of subjects: 79
Study 8690827 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine (100‐250 mg/day)
Number of subjects: 79
Study 8690827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 79
Study 8690827 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 79
Study 8690827 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study 1403224 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening class providing guidance on a self-help program for 2 hours on a group basis
Number of subjects: 224
Study 1403224 — intervention group
Group type: COMPARATOR
Intervention: 20 minutes on an individual basis during the prenatal appointment
Number of subjects: 224
Study 3908497 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% aqueous solution of Sanguinaria extract (active mouthrinse)
Number of subjects: 14
Study 3908497 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation (aqueous solution with similar color and taste)
Number of subjects: 14
Study 31415914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 53
Study 31415914 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (Control)
Number of subjects: 53
Study 29249583 — intervention group
Group type: COMPARATOR
Intervention: Left‐sided double‐lumen endotracheal tube (DLT)
Number of subjects: 45
Study 29249583 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial blocker (BB)
Number of subjects: 45
Study 26199275 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based self-monitoring and health coaching for 6 months
Number of subjects: 11
Study 26199275 — intervention group
Group type: COMPARATOR
Intervention: Health coaching without internet or smartphone-based assistance
Number of subjects: 11
Study 23494455 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT)
Number of subjects: 256
Study 23494455 — intervention group
Group type: COMPARATOR
Intervention: Panoramic radiography (PAN)
Number of subjects: 256
Study 21963214 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute coronary syndrome presentation
Number of subjects: 9
Study 21963214 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic analysis
Number of subjects: 9
Study 21963214 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraoxonase-1
Number of subjects: 9
Study 21963214 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-1-antichymotrypsin
Number of subjects: 9
Study 21963214 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-1-antitrypsin
Number of subjects: 9
Study 20446835 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic wrap
Number of subjects: 14
Study 20446835 — intervention group
Group type: EXPERIMENTAL
Intervention: Flex‐i‐Wrap
Number of subjects: 14
Study 20446835 — intervention group
Group type: COMPARATOR
Intervention: No compression
Number of subjects: 14
Study 17490971 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 1078
Study 15921471 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (n=44)
Number of subjects: 85
Study 15921471 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound (n=41)
Number of subjects: 85
Study 12444398 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental denture adhesive
Number of subjects: 37
Study 12444398 — intervention group
Group type: EXPERIMENTAL
Intervention: Marketed denture adhesive (European Fixodent Fresh)
Number of subjects: 37
Study 12444398 — intervention group
Group type: COMPARATOR
Intervention: No denture adhesive
Number of subjects: 37
Study 10624908 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 17
Study 10624908 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 750 mg
Number of subjects: 17
Study 8540713 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (dose levels ranging from 0.5 to 8.0 mg/kg of body weight)
Number of subjects: 75
Study 1950383 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (50 to 200 mg per day)
Number of subjects: 40
Study 1950383 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 40
Study 7045606 — intervention group
Group type: EXPERIMENTAL
Intervention: cinoxacin (500 mg every 12 hours)
Number of subjects: 63
Study 7045606 — intervention group
Group type: COMPARATOR
Intervention: co-trimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole every 12 hours)
Number of subjects: 63
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 g/kg bodyweight DSP
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg bodyweight DSP
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 g of 10% DSB
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 g of 15% DSB
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg bodyweight DSE
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/kg bodyweight DSE
Number of subjects: 16
Study 31623250 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 16
Study 30308973 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-matcha (theanine-rich powdered green tea)
Number of subjects: 39
Study 30308973 — intervention group
Group type: COMPARATOR
Intervention: Placebo-matcha (no expected effect)
Number of subjects: 39
Study 27657985 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar recombinant human growth hormone (r-hGH; Somatotropin)
Number of subjects: 38
Study 27657985 — intervention group
Group type: COMPARATOR
Intervention: Reference recombinant human growth hormone (Genotropin®)
Number of subjects: 38
Study 25906616 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention for perceived stress
Number of subjects: 90
Study 23204088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with distilled water (SP/W)
Number of subjects: 72
Study 23204088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with 3 percent hydrogen peroxide (SP/HP‐3)
Number of subjects: 72
Study 23204088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with 30 percent hydrogen peroxide (SP/HP‐30)
Number of subjects: 72
Study 23204088 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 percent hydrogen peroxide (HP‐35)
Number of subjects: 72
Study 23204088 — intervention group
Group type: COMPARATOR
Intervention: Control group (C1) - unbleached specimens that did not receive calcium hydroxide dressing
Number of subjects: 72
Study 23204088 — intervention group
Group type: COMPARATOR
Intervention: Control group (C2) - unbleached specimens that did receive calcium hydroxide dressing
Number of subjects: 72
Study 20378185 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 20378185 — intervention group
Group type: COMPARATOR
Intervention: Typical neuroleptics
Number of subjects: 0
Study 17277729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day) for 6 weeks
Number of subjects: 13
Study 17277729 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (not specified treatment)
Number of subjects: 13
Study 15184937 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% indomethacin, one drop three times a day
Number of subjects: 20
Study 15184937 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac, one drop three times a day
Number of subjects: 20
Study 12001776 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms of EE + 150 micrograms of DSG
Number of subjects: 60
Study 12001776 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms of EE + 150 micrograms of DSG
Number of subjects: 60
Study 12001776 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 60
Study 10460221 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular spermatozoa from men with obstructive azoospermia (n=20)
Number of subjects: 20
Study 10460221 — intervention group
Group type: COMPARATOR
Intervention: Proximal epididymal spermatozoa from men with obstructive azoospermia (n=20)
Number of subjects: 20
Study 10460221 — intervention group
Group type: COMPARATOR
Intervention: Testicular spermatozoa from men with obstructive azoospermia (n=39)
Number of subjects: 20
Study 10460221 — intervention group
Group type: COMPARATOR
Intervention: Fertile men at vasectomy (n=10)
Number of subjects: 20
Study 10460221 — intervention group
Group type: COMPARATOR
Intervention: Ejaculated spermatozoa from controls (n=5)
Number of subjects: 20
Study 10460221 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular spermatozoa from follow-up biopsy (n=9)
Number of subjects: 20
Study 7794079 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction with radiation treatment
Number of subjects: 680
Study 7794079 — intervention group
Group type: COMPARATOR
Intervention: TRAM flap breast reconstruction without radiation treatment
Number of subjects: 680
Study 7794079 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction (both groups)
Number of subjects: 680
Study 2240118 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto Suture Poly CS 57 disposable surgical stapler
Number of subjects: 200
Study 2240118 — intervention group
Group type: COMPARATOR
Intervention: Standard hysterectomy
Number of subjects: 200
Study 285103 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries-free children
Number of subjects: 0
Study 285103 — intervention group
Group type: COMPARATOR
Intervention: Caries-susceptible children
Number of subjects: 0
Study 31151340 — intervention group
Group type: EXPERIMENTAL
Intervention: 42°C PRF combined with 60°C CRF
Number of subjects: 28
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral morphine
Number of subjects: 62
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone
Number of subjects: 62
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 62
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine
Number of subjects: 62
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: All opioids
Number of subjects: 62
Study 28860712 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis of constipation (lactulose 10 mL twice daily)
Number of subjects: 62
Study 25545655 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop (auto) group
Number of subjects: 42
Study 25545655 — intervention group
Group type: COMPARATOR
Intervention: Manual (manual) group
Number of subjects: 42
Study 22795617 — intervention group
Group type: EXPERIMENTAL
Intervention: Kirtan Kriya Meditation (KKM) for 12 min daily for 8 weeks
Number of subjects: 45
Study 22795617 — intervention group
Group type: COMPARATOR
Intervention: Relaxing Music (RM) listening for 12 min daily for 8 weeks
Number of subjects: 45
Study 21078534 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention programme
Number of subjects: 185
Study 19070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-CONSORT period (2002-2007)
Number of subjects: 442
Study 19070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-CONSORT studies
Number of subjects: 442
Study 19070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall quality of reporting on psychiatric RCTs
Number of subjects: 442
Study 19070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting details of randomization, blinding, and obtaining informed consent
Number of subjects: 442
Study 16112333 — intervention group
Group type: EXPERIMENTAL
Intervention: Robinson's Original Juice Drink at 4, 25, 50, and 75 degrees C
Number of subjects: 2
Study 16112333 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribena ToothKind Juice Drink at 4, 25, 50, and 75 degrees C
Number of subjects: 2
Study 15192072 — intervention group
Group type: EXPERIMENTAL
Intervention: rLH 75 IU daily from GnRH antagonist initiation to hCG injection
Number of subjects: 218
Study 15192072 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rLH supplementation)
Number of subjects: 218
Study 11682661 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ramipril and felodipine ER (R+F)
Number of subjects: 158
Study 11682661 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (R)
Number of subjects: 158
Study 11682661 — intervention group
Group type: COMPARATOR
Intervention: Felodipine ER (F)
Number of subjects: 158
Study 10771837 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose level > or = 150 mg/dl)
Number of subjects: 758
Study 10771837 — intervention group
Group type: COMPARATOR
Intervention: Non-hyperglycemics
Number of subjects: 758
Study 10771837 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia
Number of subjects: 758
Study 8183660 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warmer (Bair Hugger)
Number of subjects: 38
Study 8183660 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninfrared radiant heater (Thermal Ceiling)
Number of subjects: 38
Study 8183660 — intervention group
Group type: COMPARATOR
Intervention: Warm blankets
Number of subjects: 38
Study 3277475 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amphotericin B (0.2 to 2 mg/kg total dose) for 2 to 6 days
Number of subjects: 224
Study 3277475 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 224
Study 3277475 — intervention group
Group type: COMPARATOR
Intervention: Antilymphocyte globulin-azathioprine
Number of subjects: 224
Study 3277475 — intervention group
Group type: COMPARATOR
Intervention: Nystatin prophylaxis
Number of subjects: 224
Study 3277475 — intervention group
Group type: EXPERIMENTAL
Intervention: Candida esophagitis
Number of subjects: 224
Study 30627885 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (109 colony-forming units) for 30 days
Number of subjects: 80
Study 30627885 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 30 days
Number of subjects: 80
Study 29708471 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS for improving feeding practices
Number of subjects: 202
Study 29708471 — intervention group
Group type: COMPARATOR
Intervention: Control SMS about infant's general health issues
Number of subjects: 202
Study 28807030 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + Ascorbic Acid
Number of subjects: 0
Study 28807030 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + Acetylsalicylic Acid
Number of subjects: 0
Study 28807030 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone (Control)
Number of subjects: 0
Study 26231516 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm of the Vitamin D and Osteoporosis Study (ViDOS)
Number of subjects: 12
Study 26231516 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations suggested by LTC teams
Number of subjects: 12
Study 23715360 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol + Ipratropium bromide (3 doses of 2.5mg Salbutamol and 500mcg Ipratropium bromide)
Number of subjects: 80
Study 23715360 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol only (3 doses of 2.5mg)
Number of subjects: 80
Study 22019576 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (24 sessions over 12 weeks)
Number of subjects: 66
Study 22019576 — intervention group
Group type: COMPARATOR
Intervention: Topiramate (4-week titration starting at 25 mg/day to a maximum of 100 mg/day followed by an 8-week maintenance)
Number of subjects: 66
Study 22019576 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 66
Study 22019576 — intervention group
Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 66
Study 17954698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftobiprole 500 mg every 12 h
Number of subjects: 784
Study 17954698 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 1 g every 12 h
Number of subjects: 784
Study 17954698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftobiprole for MRSA infections
Number of subjects: 784
Study 17954698 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin for MRSA infections
Number of subjects: 784
Study 17954698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 784
Study 17954698 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 784
Study 17306393 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT) in addition to adjuvant systemic therapy
Number of subjects: 1152
Study 17306393 — intervention group
Group type: COMPARATOR
Intervention: No postoperative radiotherapy (RT)
Number of subjects: 1152
Study 17306393 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT)
Number of subjects: 1152
Study 14973088 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (4 cups/day)
Number of subjects: 133
Study 14973088 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated black tea (4 cups/day)
Number of subjects: 133
Study 14973088 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 133
Study 11344044 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (200 or 400 microg)
Number of subjects: 26
Study 11344044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 9164811 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intravenous-feeding solutions
Number of subjects: 227
Study 9164811 — intervention group
Group type: COMPARATOR
Intervention: Aluminum-depleted intravenous-feeding solutions
Number of subjects: 227
Study 9164811 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intravenous-feeding solutions (subgroup with no neuromotor impairment)
Number of subjects: 227
Study 9164811 — intervention group
Group type: COMPARATOR
Intervention: Aluminum-depleted intravenous-feeding solutions (subgroup with no neuromotor impairment)
Number of subjects: 227
Study 8425433 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory pH monitoring
Number of subjects: 255
Study 8425433 — intervention group
Group type: COMPARATOR
Intervention: Stationary pH monitoring
Number of subjects: 255
Study 8425433 — intervention group
Group type: COMPARATOR
Intervention: Both control groups (stationary and ambulatory)
Number of subjects: 255
Study 8425433 — intervention group
Group type: COMPARATOR
Intervention: Both patient groups (stationary and ambulatory)
Number of subjects: 255
Study 8425433 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study completion
Number of subjects: 255
Study 3315086 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 46
Study 3315086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 30882151 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 985
Study 30882151 — intervention group
Group type: EXPERIMENTAL
Intervention: nicotine replacement therapy (NRT)
Number of subjects: 985
Study 30882151 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 985
Study 30882151 — intervention group
Group type: EXPERIMENTAL
Intervention: CHRNA5-CHRNA3-CHRNB4 variants
Number of subjects: 985
Study 30882151 — intervention group
Group type: EXPERIMENTAL
Intervention: adherence to medication
Number of subjects: 985
Study 30882151 — intervention group
Group type: EXPERIMENTAL
Intervention: successful smoking cessation
Number of subjects: 985
Study 29735099 — intervention group
Group type: EXPERIMENTAL
Intervention: Roasted coffee beans (Arabica and robusta)
Number of subjects: 250
Study 29735099 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification models based on geographical origin
Number of subjects: 250
Study 29735099 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee volatile concentration
Number of subjects: 250
Study 26563508 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial capnothorax (group P)
Number of subjects: 48
Study 26563508 — intervention group
Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 48
Study 24758521 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT + non-invasive extracorporeal radiofrequency (ERF)
Number of subjects: 83
Study 24758521 — intervention group
Group type: COMPARATOR
Intervention: CRT
Number of subjects: 83